<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASpecial_purpose_acquisition_company</id>
	<title>Definition:Special purpose acquisition company - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASpecial_purpose_acquisition_company"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Special_purpose_acquisition_company&amp;action=history"/>
	<updated>2026-05-15T19:34:24Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Special_purpose_acquisition_company&amp;diff=22359&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating definition</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Special_purpose_acquisition_company&amp;diff=22359&amp;oldid=prev"/>
		<updated>2026-03-30T05:49:23Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating definition&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🏦 &amp;#039;&amp;#039;&amp;#039;Special purpose acquisition company&amp;#039;&amp;#039;&amp;#039; is a publicly listed shell entity formed specifically to raise capital through an [[Definition:Initial public offering|initial public offering]] with the goal of merging with or acquiring a private company — and within insurance and [[Definition:Insurtech|insurtech]], these vehicles surged in prominence as a pathway for technology-driven insurance businesses to access public markets rapidly. Unlike a traditional IPO, where the operating company itself lists its shares, a special purpose acquisition company reverses the process: sponsors raise a pool of funds first, then identify an [[Definition:Acquisition|acquisition]] target within a defined time frame, typically two years. Several high-profile insurtech firms, [[Definition:Managing general agent|managing general agents]], and insurance-focused technology platforms pursued public listings through this route, particularly during the 2020–2021 wave of capital market activity.&lt;br /&gt;
&lt;br /&gt;
📊 The mechanics begin when sponsors — often individuals or teams with deep insurance or financial services expertise — establish the shell company, take it public at a standard unit price (commonly ten dollars per share in U.S. markets), and place the proceeds in a trust. They then search for a private insurance or insurtech target whose growth profile and strategic story appeal to public market investors. Once a target is identified, the special purpose acquisition company negotiates a [[Definition:Merger|merger]] agreement, and shareholders vote on the proposed [[Definition:Business combination|business combination]]. If approved, the target company effectively becomes public through the combined entity. For insurance-sector targets, this process often involves detailed scrutiny of [[Definition:Loss ratio|loss ratios]], [[Definition:Reserving|reserve]] adequacy, [[Definition:Regulatory capital|regulatory capital]] positions, and the sustainability of [[Definition:Underwriting|underwriting]] margins — areas where projections presented during the de-SPAC process came under significant regulatory and investor scrutiny, particularly from the U.S. [[Definition:Securities and Exchange Commission|Securities and Exchange Commission]].&lt;br /&gt;
&lt;br /&gt;
⚠️ The insurance industry&amp;#039;s experience with special purpose acquisition companies has been a mixed lesson in market discipline. Several insurtech firms that went public via this route subsequently faced steep valuation declines as their projected growth and profitability failed to materialize, prompting broader skepticism about whether the abbreviated due diligence inherent in the structure adequately accounts for the long-tail and capital-intensive nature of insurance liabilities. Regulators in the United States tightened disclosure requirements for projections used in de-SPAC transactions, and investors grew more cautious about insurance-sector targets lacking proven [[Definition:Combined ratio|combined ratios]]. Nonetheless, the mechanism demonstrated that [[Definition:Capital markets|capital markets]] appetite for insurance innovation remains strong when the underlying business fundamentals are sound. For industry observers, the special purpose acquisition company era underscored the importance of rigorous [[Definition:Actuarial analysis|actuarial analysis]] and transparent financial reporting when bringing insurance enterprises to public ownership, regardless of the listing vehicle chosen.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Initial public offering]]&lt;br /&gt;
* [[Definition:Insurtech]]&lt;br /&gt;
* [[Definition:Capital markets]]&lt;br /&gt;
* [[Definition:Mergers and acquisitions]]&lt;br /&gt;
* [[Definition:Private equity]]&lt;br /&gt;
* [[Definition:Regulatory capital]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>